Case study of Pharmacy Industry

Name of Industry or Sector (Strategic Group)The Pharmaceutical Industry Threat of new entrants Several aspects have been taken into consideration for the threat of new entrants. Firstly, the expenditure of R&D is too costly, especially for the branded prescription drugs. Regarding the pipeline, it takes too long a time for new drugs to move from discovery to market, nearly 12 years. In this situation, the spending on R&D is high due …

…and Cases, England: Pearson Education Limited, p. 630-650. Others: Humer, Franz B. 'The Pharmaceutical Industry in the Global Economy'. Nov 20, 2002. Oct 26, 2003 < http://mitworld.mit.edu/video/59/>. Smith, Nancy DuVergne (Dec 18, 2002). 'Pharmaceutical Industry balances Profits, Moral Responsibilities'. Oct 26, 2003 <http://web.mit.edu/newsoffice/tt/2002/dec18/humer.html>. Weber, Joseph, Amy Barrett, Michael Mandel and Jeff Laderman (Nov 5, 1998). 'The New Ear of Lifestyle Drugs'. Oct 27, 2003 <http://www.businessweek.com/1998/19/topstory.htm>.